Haematological toxicity of carboplatin in rats

British Journal of Cancer

Volumn 55, Issue 4, 1987, Pages 375-379

  Siddik, Z H ^a   Boxall, F E ^a   Harrap, K R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; RADIOISOTOPE;

ANEMIA; ANIMAL EXPERIMENT; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW TOXICITY; DRUG INDUCED ANEMIA; DRUG TOXICITY; INTOXICATION; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY;

ANEMIA; ANIMAL; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CARBOPLATIN; CISPLATIN; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE AGING; FEMALE; HEMATOLOGIC DISEASES; LEUKOPENIA; ORGANOPLATINUM COMPOUNDS; OSMOTIC FRAGILITY; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0023253856     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1987.75     Document Type: Article

References (16)

1. BELCHER, E.H. & HARRISS, E.B. (1959). Studies of red cell life span in the rat. J. Physiol., 146, 217.
2. CALVERT, A.H., HARLAND, S.J., NEWELL, D.R. & 9 others (1982). Early clinical studies with cis-diammine- 1, 1 -cyclobutane dicarboxylate platinum II. Cancer Chemother. Pharmacol., 9, 140.
3. CROCKER, C.L. (1967). Rapid determination of urea nitrogen in serum or plasma without deproteinisation. Am. J. Med. Technol., 33, 361.
4. DACIE, J.V. & LEWIS, S.M. (1975). Practical Haematology. Churchill Livingstone: Edinburgh.
5. DELANEY, J.W. & GARRATTY, G. (1969). Handbook of Haematological and Blood Transfusion Techniques. Butterworths: London.
6. GETAZ, E.P., BECKLEY, S., FITZPATRICK, J. & DOZIER, A. (1980). Cis-platin-induced haemolysis. N. Engl. J. Med., 302, 334.
7. HARRAP, K.R., JONES, M., WILKINSON, C.R. & 5 others (1980). Antitumour, toxic and biochemical properties of cis-platin and eight other platinum complexes. In Cis-platin: Current Status and New Developments, (eds.) Prestayko, A.W., et al., p. 193. Academic Press, New York.
8. INTERNATIONAL COMMITTEE FOR STANDARDISATION IN HAEMATOLOGY (1971). Recommended methods for radioisotope red cell survival studies. Blood, 38, 378.
9. JENNRICH, R.I. & SAMPSON, P.F. (1968). Application of stepwise regression to non-linear least squares estimation. Technometrics, 10, 63.
10. LEVINE, B.S., HENRY, M.C., PORT, C.D., RICHTER, W.R. & URBANEK, M.A. (1981). Nephrotoxic potential of cis-diamminedichloroplatinum and four analogues in male Fischer 344 rats. J. Natl. Cancer Inst., 67, 201.
11. NGUYEN, B.V., JAFFE, N. & LICHTIGER, B. (1981). Cis-platininduced anaemia. Cancer Treat. Rep., 65, 1121.
12. NOWROUSIAN, M.R. & SCHMIDT, C.G. (1982). Effects of cis-platin on different haemopoietic progenitor cells in mice. Br. J. Cancer, 46, 397.
13. OTTAWAY, J.H. (1973). Normalisation in the fitting of data by iterative methods: Application to tracer kinetics and enzyme kinetics. Biochem. J., 134, 729.
14. PRESTAYKO, A.W., D'AOUST, J.C., ISSELL, B.F. & CROOKE, S.T. (1979). Cis-platin (cis-diamminedichloroplatinum II). Cancer Treat. Rev., 6, 17.
15. VON HOFF, D.D. & ROZENCWEIG, M. (1979). Cis-Diamminedichloroplatinum (II): A metal complex with significant antitumour activity. Adv. Pharmacol. Chemother., 16, 273.
16. WILTSHAW, E., EVANS, B.D., JONES, A.C., BAKER, J.W. & CALVERT, A.H. (1983). JM8, successor to cis-platin in advanced ovarian carcinoma. Lancet, i, 587.